Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Casneuf et al.

  • Leukemia
  • May 2020

Cellular Origins and Genetic Landscape of Cutaneous Gamma Delta T Cell Lymphomas

Daniels et al.

  • Nature Communications
  • April 2020

Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma

Dheilly et al.

  • Cancer Cell
  • April 2020

T-cell lymphoma secondary to checkpoint inhibitor therapy

Anand et al.

  • Journal for ImmunoTherapy of Cancer
  • February 2020

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Perumal et al.

  • Clinical Cancer Research
  • January 2020

Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy

Sheih et al.

  • Nature Communications
  • January 2020

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Xu-Monette et al.

  • Journal for ImmunoTherapy of Cancer
  • October 2019

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK1 lymphoma after transplantation

Rajan et al.

  • Blood Advances
  • June 2019

Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma

Vieyra-Garcia et al.

  • JCI Insight
  • January 2019